FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2986197603> ?p ?o ?g. }

• W2986197603 abstract "Introduction/Background The alpha parameter characterizes the ratio of single-stranded and double-stranded nucleic acids in the lymphocyte. The values of this parameter can be used as a signal test containing generalized information about the complex of changes in the body of a cancer patient. The purpose of the study was to perform a luminescent-spectral analysis of peripheral blood lymphocytes in patients with ovarian cancer (OC) during antitumor treatment. Methodology Peripheral blood lymphocytes of 20 patients with T3NxMo OC were studied. Patients received endolymphatic polychemotherapy (thiotepa 200 mg, metatrexate 100 mg, 5-fluorouracil 200 mg) twice with a 1-week interval. Lymphocytes isolated during the treatment were stained by the Karnaukhov-Rigler method and studied using a microspectrofluorimeter. Fluorescent spectral analysis was performed. Results The spectra of OC patients before treatment had only one emission band at 530 nm, with low α parameter values (0.098–0.1 SU). After the beginning of the treatment, a second band appeared on the spectrum at 640 nm, however the band at 530 nm prevailed. During the antitumor treatment and achievement of clinical effect, the intensity of the band at 530 nm significantly decreased on the spectrum in favor of a wavelength of 640 nm. After the end of antitumor therapy, both peaks of approximately the same intensity were present on the spectrum. With the normalization of patients‘ state, α parameter values increased from 0.44 SU to 2.12 SU (p≤0.05). The values were low (0.22–0.048SU) when the state of patients worsened, without clinical effect. Conclusion The shape of the luminescence spectrum and values of the α parameter vary during the treatment and depend on its results. Luminescent characteristics of peripheral blood lymphocytes allow monitoring the treatment effectiveness and can help to objectively assess the condition of ovarian cancer patients. Disclosure Nothing to disclose." @default.
• W2986197603 created "2019-11-22" @default.
• W2986197603 creator A5000809361 @default.
• W2986197603 creator A5012544880 @default.
• W2986197603 creator A5033349267 @default.
• W2986197603 creator A5037629702 @default.
• W2986197603 creator A5054311594 @default.
• W2986197603 creator A5083709718 @default.
• W2986197603 date "2019-11-01" @default.
• W2986197603 modified "2023-09-23" @default.
• W2986197603 title "EP1020 Luminescent characteristics of peripheral blood lymphocytes reflect efficiency of treatment in patients with ovarian cancer" @default.
• W2986197603 doi "https://doi.org/10.1136/ijgc-2019-esgo.1064" @default.
• W2986197603 hasPublicationYear "2019" @default.
• W2986197603 type Work @default.
• W2986197603 sameAs 2986197603 @default.
• W2986197603 citedByCount "0" @default.
• W2986197603 crossrefType "proceedings-article" @default.
• W2986197603 hasAuthorship W2986197603A5000809361 @default.
• W2986197603 hasAuthorship W2986197603A5012544880 @default.
• W2986197603 hasAuthorship W2986197603A5033349267 @default.
• W2986197603 hasAuthorship W2986197603A5037629702 @default.
• W2986197603 hasAuthorship W2986197603A5054311594 @default.
• W2986197603 hasAuthorship W2986197603A5083709718 @default.
• W2986197603 hasConcept C121608353 @default.
• W2986197603 hasConcept C126322002 @default.
• W2986197603 hasConcept C2776694085 @default.
• W2986197603 hasConcept C2776755627 @default.
• W2986197603 hasConcept C2777761686 @default.
• W2986197603 hasConcept C2779968505 @default.
• W2986197603 hasConcept C2780427987 @default.
• W2986197603 hasConcept C2989005 @default.
• W2986197603 hasConcept C3017910909 @default.
• W2986197603 hasConcept C46762472 @default.
• W2986197603 hasConcept C71924100 @default.
• W2986197603 hasConcept C90924648 @default.
• W2986197603 hasConceptScore W2986197603C121608353 @default.
• W2986197603 hasConceptScore W2986197603C126322002 @default.
• W2986197603 hasConceptScore W2986197603C2776694085 @default.
• W2986197603 hasConceptScore W2986197603C2776755627 @default.
• W2986197603 hasConceptScore W2986197603C2777761686 @default.
• W2986197603 hasConceptScore W2986197603C2779968505 @default.
• W2986197603 hasConceptScore W2986197603C2780427987 @default.
• W2986197603 hasConceptScore W2986197603C2989005 @default.
• W2986197603 hasConceptScore W2986197603C3017910909 @default.
• W2986197603 hasConceptScore W2986197603C46762472 @default.
• W2986197603 hasConceptScore W2986197603C71924100 @default.
• W2986197603 hasConceptScore W2986197603C90924648 @default.
• W2986197603 hasLocation W29861976031 @default.
• W2986197603 hasOpenAccess W2986197603 @default.
• W2986197603 hasPrimaryLocation W29861976031 @default.
• W2986197603 hasRelatedWork W185204666 @default.
• W2986197603 hasRelatedWork W2069338981 @default.
• W2986197603 hasRelatedWork W2168138945 @default.
• W2986197603 hasRelatedWork W2302929670 @default.
• W2986197603 hasRelatedWork W2366060979 @default.
• W2986197603 hasRelatedWork W2910073078 @default.
• W2986197603 hasRelatedWork W3139546918 @default.
• W2986197603 hasRelatedWork W3185632624 @default.
• W2986197603 hasRelatedWork W51052886 @default.
• W2986197603 hasRelatedWork W2185554263 @default.
• W2986197603 isParatext "false" @default.
• W2986197603 isRetracted "false" @default.
• W2986197603 magId "2986197603" @default.
• W2986197603 workType "article" @default.